Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PROTEIN DESIGN LABS INC/DE | 46,275 | reported | 20 Jul 2007 | tx 242+290,800−592,925 |
| CYTOKINETICS INC | 15,000 | reported | 21 May 2009 | tx 5+55,000 |
| FIVE PRIME THERAPEUTICS INC | 10,000 | reported | 10 May 2018 | tx 10+77,601−12,601 |
| Dermira, Inc. | 0 | reported | 20 Feb 2020 | tx 21+74,377−74,377 |
| 0 |
| reported |
| 02 Nov 2018 |
| tx 6+4,153.44−6,464.56 |
| Talaris Therapeutics, Inc. | 0 | reported | 28 Oct 2025 | tx 16+530,750−809,509 |
| Icosavax, Inc. | 0 | reported | 19 Feb 2024 | tx 8+87,046−3,605,292 |
| Aimmune Therapeutics, Inc. | 0 | reported | 13 Oct 2020 | tx 17+106,277−211,119 |
2 purchases reported after at least 12 months of silence — most recent on 29 Jan 2024.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 Oct 2025 | TENDER | Talaris Therapeutics, Inc. | 448,431 | — | |
| 28 Oct 2025 | TENDER | Talaris Therapeutics, Inc. | 110,083 | — | |
| 28 Oct 2025 | TENDER | Talaris Therapeutics, Inc. | 183,177 | — | |
| 28 Oct 2025 | TENDER | Talaris Therapeutics, Inc. | 518 | — | |
| 28 Oct 2025 | OTHER | Talaris Therapeutics, Inc. | 16,800 | — | deriv |
| 28 Oct 2025 | OTHER | Talaris Therapeutics, Inc. | 10,000 | — | deriv |
| 28 Oct 2025 | OTHER | Talaris Therapeutics, Inc. | 20,000 | — | deriv |
| 04 Jun 2025 | GRANT_AWARD | Talaris Therapeutics, Inc. | 16,800 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Talaris Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 19 Feb 2024 | TENDER | Icosavax, Inc. | 55,786 | — | |
| 19 Feb 2024 | TENDER | Icosavax, Inc. | 3,510,228 | — | |
| 19 Feb 2024 | OTHER | Icosavax, Inc. | 17,000 | — | deriv |
| 19 Feb 2024 | OTHER | Icosavax, Inc. | 22,278 | — | deriv |
| 29 Jan 2024 | PURCHASE | Talaris Therapeutics, Inc. | 100,000 | 32.50 USD | first after silence |
| 19 Oct 2023 | GRANT_AWARD | Talaris Therapeutics, Inc. | 348,431 | — | |
| 19 Oct 2023 | GRANT_AWARD | Talaris Therapeutics, Inc. | 518 | — | |
| 19 Oct 2023 | OTHER | Talaris Therapeutics, Inc. | 20,500 | 0.00 USD | deriv |
| 23 Oct 2023 | GRANT_AWARD | Talaris Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 13 Jun 2023 | GRANT_AWARD | Talaris Therapeutics, Inc. | 20,500 | 0.00 USD | deriv |
| 06 Jun 2023 | GRANT_AWARD | Icosavax, Inc. | 17,000 | 0.00 USD | deriv |
| 10 Jun 2022 | GRANT_AWARD | Icosavax, Inc. | 5,543 | 0.00 USD | |
| 10 Jun 2022 | GRANT_AWARD | Icosavax, Inc. | 22,278 | 0.00 USD | deriv |
| 09 Jun 2022 | GRANT_AWARD | Talaris Therapeutics, Inc. | 14,501 | 0.00 USD | deriv |
| 01 Apr 2022 | PURCHASE | Icosavax, Inc. | 42,225 | 7.10 USD | first after silence |
| 13 Oct 2020 | OTHER | Aimmune Therapeutics, Inc. | 7,840 | 34.50 USD |